Sharps Technology (NASDAQ:STSS) versus NWT Uranium (OTCMKTS:CPTRF) Head to Head Survey

Sharps Technology (NASDAQ:STSS) and NWT Uranium (OTCMKTS:CPTRF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Institutional and Insider Ownership

17.2% of Sharps Technology shares are held by institutional investors. 1.2% of Sharps Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Sharps Technology and NWT Uranium’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-8.72%	-5.30%
NWT Uranium	N/A	-85.62%	-77.66%

Valuation and Earnings

This table compares Sharps Technology and NWT Uranium”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sharps Technology	N/A	N/A	-$9.30 million	($1,212.34)	0.00
NWT Uranium	$27.25 million	N/A	$6.69 million	$4.08	0.04

NWT Uranium has higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a lower price-to-earnings ratio than NWT Uranium, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and price targets for Sharps Technology and NWT Uranium, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	1	0	0	0	1.00
NWT Uranium	0	0	0	0	0.00

Summary

Sharps Technology beats NWT Uranium on 6 of the 9 factors compared between the two stocks.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

About NWT Uranium

Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.